Zanamivir
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 55 (5) , 721-725
- https://doi.org/10.2165/00003495-199855050-00015
Abstract
▴ Zanamivir is the first of a new class of selective influenza virus neuraminidase inhibitors. It inhibits both influenza A and influenza B virus replication in vitro. ▴ In the ferret model of influenza, zanamivir reduced viral replication and diminished pyrexia associated with the infection. ▴ Repeated passageof influenza virus in the presence of zanamivir could produce resistance in vitro. However, there have been no changes in sensitivity to zanamivir in any influenza virus isolates from patients receiving zanamivir in clinical trials. ▴ In experimental infection in humans, in which the virus replicates only in the nasal passages, intranasal zanamivir (3.6 to 16mg) prevented infection with influenza virus. A combination of inhaled (10mg) and intranasal (6.4mg) zanamivir for 14 days was effective in preventing influenza in a nursing home setting during an influenza A virus outbreak. ▴ Inhaled zanamivir (10mg) with or without intranasal zanamivir (6.4mg) reduced the time to alleviation of influenza symptoms compared with placebo in patients with confirmed infection.Keywords
This publication has 11 references indexed in Scilit:
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus InfectionsNew England Journal of Medicine, 1997
- Selection of Influenza A and B Viruses for Resistance to 4‐Guanidino‐Neu5Ac2en in Cell CultureThe Journal of Infectious Diseases, 1997
- Safety and Efficacy of the Neuraminidase Inhibitor GG167 in Experimental Human InfluenzaJAMA, 1996
- GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferretsAntimicrobial Agents and Chemotherapy, 1995
- Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epitheliumAntiviral Research, 1994
- Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase)Antimicrobial Agents and Chemotherapy, 1994
- Inhibition of the growth of influenza viruses in vitro by 4-guanidino-2,4-dideoxy-N-acetylneuraminic acidAntiviral Research, 1994
- Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: A double-blind, multicenter, placebo-controlled trialThe Journal of Pediatrics, 1994
- Amantadine and Rimantadine Prophylaxis of Influenza A in Nursing HomesDrugs & Aging, 1994
- 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitroAntimicrobial Agents and Chemotherapy, 1993